Sepsis induces long-term metabolic and mitochondrial muscle stem cell dysfunction amenable by mesenchymal stem cell therapy

Nature Communications

Volumn 6, Issue , 2015, Pages

  Rocheteau, P ^a   Chatre, L ^a,b   Briand, D ^a   Mebarki, M ^a   Jouvion, G ^a   Bardon, J ^a   Crochemore, C ^a,b   Serrani, P ^a   Lecci, P P ^a   Latil, M ^a   Matot, B ^c,d   Carlier, P G ^c,d   Latronico, N ^e   Huchet, C ^b   Lafoux, A ^b   Sharshar, T ^a,f,g,h   Ricchetti, M ^a,b   Chretien F ^a,h,i,j  

^a INSTITUT PASTEUR   (France)

^b L INSTITUT DU THORAX   (France)

^c Institute of Myology   (France)

^d DIF   (France)

^e UNIVERSITY OF BRESCIA   (Italy)

^f RAYMOND POINCARÉ HOSPITAL   (France)

^g LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^h TRIGGERSEP   (France)

ⁱ CENTRE HOSPITALIER SAINTE ANNE   (France)

^j UNIVERSITÉ PARIS DESCARTES   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; CYTOKINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; SUPEROXIDE DISMUTASE; REACTIVE OXYGEN METABOLITE;

CELL ORGANELLE; MALNUTRITION; MEMBRANE; MORBIDITY; MUSCLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENERGY METABOLISM; MALNUTRITION; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLIC DISORDER; MOUSE; MUSCLE ATROPHY; MUSCLE REGENERATION; MUSCLE STEM CELL; MUSCLE STRENGTH; MUSCLE WEAKNESS; NONHUMAN; PROTEIN DEGRADATION; SATELLITE CELL; SEPSIS; ANIMAL; CELL CULTURE; COMPLICATION; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; MUSCLE MITOCHONDRION; PATHOLOGY; PERITONITIS; REGENERATION; SKELETAL MUSCLE SATELLITE CELL; STEM CELL; TRANSGENIC MOUSE;

ANIMALS; CELLS, CULTURED; CYTOKINES; GENE EXPRESSION REGULATION; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MICE; MICE, TRANSGENIC; MITOCHONDRIA, MUSCLE; PERITONITIS; REACTIVE OXYGEN SPECIES; REGENERATION; SATELLITE CELLS, SKELETAL MUSCLE; SEPSIS; STEM CELLS;

EID: 84950107039     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms10145     Document Type: Article

References (51)

1. Cohen, J. The immunopathogenesis of sepsis. Nature 420, 885-891 (2002).
2. Gamrin, L., et al. Longitudinal changes of biochemical parameters in muscle during critical illness. Metabolism 46, 756-762 (1997).
3. Mittendorfer, B., Gore, D. C., Herndon, D. N. & Wolfe, R. R. Accelerated glutamine synthesis in critically ill patients cannot maintain normal intramuscular free glutamine concentration. JPEN J. Parenter. Enteral Nutr. 23, 243-250 discussion 250-242 (1999).
4. Rennie, M. J., et al. Glutamine metabolism and transport in skeletal muscle and heart and their clinical relevance. J. Nutr. 126, 1142S-1149S (1996).
5. Windmueller, H. G. & Spaeth, A. E. Respiratory fuels and nitrogen metabolism in vivo in small intestine of fed rats. Quantitative importance of glutamine, glutamate, and aspartate. J. Biol. Chem. 255, 107-112 (1980).
6. Newsholme, E. A. & Parry-Billings, M. Properties of glutamine release from muscle and its importance for the immune system. JPEN J. Parenter. Enteral Nutr. 14, 63S-67S (1990).
7. Vary, T. C. & Kimball, S. R. Regulation of hepatic protein synthesis in chronic inflammation and sepsis. Am. J. Physiol. 262, C445-C452 (1992).
8. Langhans, C., et al. Inflammation-induced acute phase response in skeletal muscle and critical illness myopathy. PLoS ONE 9, e92048 (2014).
9. Reid, W. D. & MacGowan, N. A. Respiratory muscle injury in animal models and humans. Mol. Cell. Biochem. 179, 63-80 (1998).
10. Bonaldo, P. & Sandri, M. Cellular and molecular mechanisms of muscle atrophy. Dis. Model Mech. 6, 25-39 (2013).
11. Wollersheim, T., et al. Dynamics of myosin degradation in intensive care unit-acquired weakness during severe critical illness. Intensive Care Med. 40, 528-538 (2014).
12. Herridge, M. S., et al. Functional disability 5 years after acute respiratory distress syndrome. N. Engl. J. Med. 364, 1293-1304 (2011).
13. Iwashyna, T. J., Ely, E. W., Smith, D. M. & Langa, K. M. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA 304, 1787-1794 (2010).
14. Lepper, C., Partridge, T. A. & Fan, C. M. An absolute requirement for Pax7-positive satellite cells in acute injury-induced skeletal muscle regeneration. Development 138, 3639-3646 (2011).
15. Murphy, M. M., Lawson, J. A., Mathew, S. J., Hutcheson, D. A. & Kardon, G. Satellite cells, connective tissue fibroblasts and their interactions are crucial for muscle regeneration. Development 138, 3625-3637 (2011).
16. Sambasivan, R., et al. Pax7-expressing satellite cells are indispensable for adult skeletal muscle regeneration. Development 138, 3647-3656 (2011).
17. Trachootham, D., Lu, W., Ogasawara, M. A., Nilsa, R. D. & Huang, P. Redox regulation of cell survival. Antioxid. Redox Signal. 10, 1343-1374 (2008).
18. Sambasivan, R., et al. Distinct regulatory cascades govern extraocular and pharyngeal arch muscle progenitor cell fates. Dev. Cell 16, 810-821 (2009).
19. Davis, R. L., Weintraub, H. & Lassar, A. B. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 51, 987-1000 (1987).
20. Lassar, A. B., Paterson, B. M. & Weintraub, H. Transfection of a DNA locus that mediates the conversion of 10T1/2 fibroblasts to myoblasts. Cell 47, 649-656 (1986).
21. Andres, V. & Walsh, K. Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis. J. Cell Biol. 132, 657-666 (1996).
22. Malec, V., et al. HIF-1 alpha signaling is augmented during intermittent hypoxia by induction of the Nrf2 pathway in NOX1-expressing adenocarcinoma A549 cells. Free Radic. Biol. Med. 48, 1626-1635 (2010).
23. Pamplona, R. & Costantini, D. Molecular and structural antioxidant defenses against oxidative stress in animals. Am. J. Physiol. Regul. Integr. Comp. Physiol. 301, R843-R863 (2011).
24. Taylor-Fishwick, D. A. NOX, NOX who is there? The contribution of NADPH oxidase one to beta cell dysfunction. Front. Endocrinol. (Lausanne) 4, 40 (2013).
25. Tsang, C. K., Liu, Y., Thomas, J., Zhang, Y. & Zheng, X. F. Superoxide dismutase 1 acts as a nuclear transcription factor to regulate oxidative stress resistance. Nat. Commun. 5, 3446 (2014).
26. Doridot, L., et al. Nitroso-redox balance and mitochondrial homeostasis are regulated by STOX1, a pre-eclampsia-associated gene. Antioxid. Redox Signal. 21, 819-834 (2014).
27. Handschin, C. & Spiegelman, B. M. The role of exercise and PGC1alpha in inflammation and chronic disease. Nature 454, 463-469 (2008).
28. Chatre, L. & Ricchetti, M. Large heterogeneity of mitochondrial DNA transcription and initiation of replication exposed by single-cell imaging. J. Cell Sci. 126, 914-926 (2013).
29. Latil, M., et al. Skeletal muscle stem cells adopt a dormant cell state post mortem and retain regenerative capacity. Nat. Commun. 3, 903 (2012).
30. Xu, X., et al. Mitochondrial regulation in pluripotent stem cells. Cell Metab. 18, 325-332 (2013).
31. Matthay, M. A., Goolaerts, A., Howard, J. P. & Lee, J. W. Mesenchymal stem cells for acute lung injury: preclinical evidence. Crit. Care Med. 38, S569-S573 (2010).
32. Prockop, D. J., Kota, D. J., Bazhanov, N. & Reger, R. L. Evolving paradigms for repair of tissues by adult stem/progenitor cells (MSCs). J. Cell. Mol. Med. 14, 2190-2199 (2010).
33. Weiss, D. J., Kolls, J. K., Ortiz, L. A., Panoskaltsis-Mortari, A. & Prockop, D. J. Stem cells and cell therapies in lung biology and lung diseases. Proc. Am. Thorac. Soc. 5, 637-667 (2008).
34. Yagi, H., et al. Reactive bone marrow stromal cells attenuate systemic inflammation via sTNFR1. Mol. Ther. 18, 1857-1864 (2010).
35. Houlihan, D. D., et al. Isolation of mouse mesenchymal stem cells on the basis of expression of Sca-1 and PDGFR-alpha. Nat. Protoc. 7, 2103-2111 (2012).
36. Hotchkiss, R. S. & Nicholson, D. W. Apoptosis and caspases regulate death and inflammation in sepsis. Nat. Rev. Immunol. 6, 813-822 (2006).
37. Pittenger, M. F., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143-147 (1999).
38. Wakitani, S., Saito, T. & Caplan, A. I. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 18, 1417-1426 (1995).
39. Caplan, A. I. Mesenchymal stem cells. J. Orthopaed. Res. 9, 641-650 (1991).
40. Kelly, R., Alonso, S., Tajbakhsh, S., Cossu, G. & Buckingham, M. Myosin light chain 3F regulatory sequences confer regionalized cardiac and skeletal muscle expression in transgenic mice. J. Cell Biol. 129, 383-396 (1995).
41. Huchet, C. & Leoty, C. Effects of cyclopiazonic acid on Ca(2+)-activated tension production in skinned skeletal muscle fibres of the ferret. Eur. J. Pharmacol. 241, 41-46 (1993).
42. Godt, R. E. & Nosek, T. M. Changes of intracellular milieu with fatigue or hypoxia depress contraction of skinned rabbit skeletal and cardiac muscle. J. Physiol. 412, 155-180 (1989).
43. De Jonghe, B., et al. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA 288, 2859-2867 (2002).
44. De Letter, M. A., et al. Critical illness polyneuropathy and myopathy (CIPNM): evidence for local immune activation by cytokine-expression in the muscle tissue. J. Neuroimmunol. 106, 206-213 (2000).
45. Fletcher, S. N., et al. Persistent neuromuscular and neurophysiologic abnormalities in long-term survivors of prolonged critical illness. Crit. Care Med. 31, 1012-1016 (2003).
46. Zifko, U. A. Long-term outcome of critical illness polyneuropathy. Muscle Nerve Suppl. 9, S49-S52 (2000).
47. dos Santos, C. C., et al. Network analysis of transcriptional responses induced by mesenchymal stem cell treatment of experimental sepsis. Am. J. Pathol. 181, 1681-1692 (2012).
48. Hall, S. R., et al. Mesenchymal stromal cells improve survival during sepsis in the absence of heme oxygenase-1: the importance of neutrophils. Stem Cells 31, 397-407 (2013).
49. Kusadasi, N. & Groeneveld, A. B. A perspective on mesenchymal stromal cell transplantation in the treatment of sepsis. Shock 40, 352-357 (2013).
50. Mei, S. H., et al. Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. Am. J. Respir. Crit. Care Med. 182, 1047-1057 (2010).
51. Nemeth, K., et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat. Med. 15, 42-49 (2009).